Early intervention needs to be a ‘team sport’ to curb checkpoint inhibitor-related irAEs

Early intervention is critical in managing patients with immune-related adverse events associated with cancer checkpoint inhibitor therapy, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.
“This is something that all of us will be drawn into in the near-term future,” Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, and professor of medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, said in his presentation. “It is not one disease, it is many diseases.”
Calabrese warned that all organ

Source link

Related posts

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function


C. Diff Carriers May Pose Hidden Infection Threat


An Unusual Cause of Post-Polypectomy Bleeding


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World